UnitedHealth Group (NYSE:UNH) Price Target Lowered to $660.00 at Wells Fargo & Company

UnitedHealth Group (NYSE:UNH - Get Free Report) had its price objective reduced by equities researchers at Wells Fargo & Company from $694.00 to $660.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has an "overweight" rating on the healthcare conglomerate's stock. Wells Fargo & Company's target price suggests a potential upside of 21.70% from the stock's previous close.

Several other equities analysts have also weighed in on the stock. Bank of America cut their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating on the stock in a research report on Wednesday, October 16th. StockNews.com raised shares of UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Morgan Stanley decreased their price target on UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating for the company in a research note on Wednesday, October 16th. Truist Financial decreased their target price on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a research report on Monday, January 6th. Finally, Hsbc Global Res raised shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a report on Friday, January 10th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Buy" and an average target price of $629.32.

UnitedHealth Group Stock Performance

UNH stock traded down $3.27 on Tuesday, reaching $542.30. The company's stock had a trading volume of 1,811,462 shares, compared to its average volume of 4,441,151. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group has a 52 week low of $436.38 and a 52 week high of $630.73. The firm has a fifty day moving average of $537.14 and a two-hundred day moving average of $564.96. The company has a market capitalization of $499.07 billion, a P/E ratio of 34.99, a price-to-earnings-growth ratio of 1.46 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $100.81 billion during the quarter, compared to analysts' expectations of $101.60 billion. During the same period last year, the firm posted $5.83 earnings per share. The business's revenue was up 6.8% on a year-over-year basis. As a group, analysts predict that UnitedHealth Group will post 29.64 EPS for the current fiscal year.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the business's stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.33% of the stock is owned by insiders.

Hedge Funds Weigh In On UnitedHealth Group

A number of institutional investors and hedge funds have recently bought and sold shares of the business. State Street Corp lifted its stake in shares of UnitedHealth Group by 1.3% during the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate's stock valued at $26,626,387,000 after acquiring an additional 563,554 shares during the period. Geode Capital Management LLC boosted its stake in shares of UnitedHealth Group by 1.6% in the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate's stock valued at $11,440,133,000 after purchasing an additional 318,039 shares during the last quarter. Franklin Resources Inc. lifted its holdings in UnitedHealth Group by 2.5% in the third quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate's stock valued at $4,884,019,000 after buying an additional 193,800 shares during the period. International Assets Investment Management LLC grew its holdings in UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate's stock worth $3,096,896,000 after acquiring an additional 5,290,025 shares during the period. Finally, Fisher Asset Management LLC boosted its position in shares of UnitedHealth Group by 3.5% in the 3rd quarter. Fisher Asset Management LLC now owns 3,197,167 shares of the healthcare conglomerate's stock worth $1,869,320,000 after purchasing an additional 107,097 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.